Modern approach to basal-bolus therapy with glargine and glulisine insulin analoguesin various age groups

QR Code

Modern approach to basal-bolus therapy with glargine and glulisine insulin analoguesin various age groups

DCCT (Diabetes Control and Complications Trial) study established that intensified insulin therapy in multiple daily injections (MDI) or continuous insulin infusion (CSII) regimens substantially reduce both development and progression of complications in patients with type 1 diabetes mellitus (T1DM)...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Natalya Nikitichna Volevodz, Dmitriy Nikitich Laptev, Marina Vladimirovna Shestakova
Format:	article
Langue:	EN RU
Publié:	Endocrinology Research Centre 2013
Sujets:	diabetes mellitus insulin analogues hypoglycemia Nutritional diseases. Deficiency diseases RC620-627
Accès en ligne:	https://doaj.org/article/e2aff6d78bf2450a90afabf1468d9f15
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Comparative efficacy assessment for various insulin regimens in patients with type 2 diabetes mellitus, ischaemic heart disease and frequent hypoglycemic events
par: Vladimir Ivanovich Kudinov, et autres
Publié: (2012)

Insulin degludec/insulin aspart is the first co-formulation of basal and prandial insulin analogues
par: Ivan Ivanovich Dedov, et autres
Publié: (2014)

Insulin glargine: pharmacokinetic and pharmacodynamic basis of clinical effect
par: Vadim Valer'evich Klimontov, et autres
Publié: (2014)

Insulin degludec: a new basal insulin analogue with an ultra-long duration of action. Safety and efficacy in Russian patients with diabetes
par: Marina Vladimirovna Shestakova, et autres
Publié: (2015)

On the safety of insulin Glargine
par: Ivan Ivanovich Dedov, et autres
Publié: (2009)

The first and only combination of basal and prandial insulin analogs degludec and aspart: the position of Russian endocrinologists
par: M. V. Shestakova, et autres
Publié: (2021)

Modern basal insulins: an ongoing story or the start of a new era?
par: Ivan Ivanovich Dedov
Publié: (2015)

On the centenary of the insulin discovery
par: I. I. Dedov, et autres
Publié: (2021)

Modern approach to the evaluation of the pharmacokinetics and pharmacodynamics of biosimilar recombinant human insulin and insulin analogues in I phase clinical study
par: Irina A. Proskurina, et autres
Publié: (2016)

Arrhythmogenic effects of hypoglycemia in children and adolescents with type 1 diabetes mellitus
par: Dmitriy Nikitich Laptev, et autres
Publié: (2013)

A1chieve Program in Russian Federation: a multicenter prospective observational study of insulin analogue treatment efficiency and safety in daily management of patients with type 2 diabetes mellitus, who startand intensify insulin treatment having never received it before
par: Marina Vladimirovna Shestakova
Publié: (2012)

Metabolic and cardiovascular effects of early insulin glargin prescription: based on data from ORIGIN study
par: Elena Valer'evna Biryukova, et autres
Publié: (2012)

Arrhythmogenic effects of hypoglycemia
par: Dmitriy Nikitich Laptev, et autres
Publié: (2012)

Dose adjustment in insulin pump therapy: optimization of bolus calculator settings
par: Yury Ivanovich Filippov, et autres
Publié: (2012)

Efficacy and safety of treatment with human insulin analogues in daily management of insulin naive patients with type 2 diabetes mellitus: results of multicenter 52-week observational study A1chive
par: Marina Vladimirovna Shestakova
Publié: (2012)

Insulin glargine does not increase the risk of malignancy.Synopsis of the article ?Combined randomised controlled trial experience of malignancies in studies using insulin glargine?byHome P.D. & Lagarenne P. (Diabetologia 2009, vol. 52 (12): 2499-2506)
par: Marina Vladimirovna Shestakova, et autres
Publié: (2010)

Individual stepwise intensification of insulin analogue therapy in type 2 diabetes mellitus
par: Alexander Sergeevich Ametov, et autres
Publié: (2012)

Challenges and unmet needs in basal insulin therapy: lessons from the Asian experience
par: Chan WB, et autres
Publié: (2017)

Effects of metformin on body weight in patients with type 2 diabetes mellitus,receiving insulin analogue treatment
par: Tatiana Ivanovna Romantsova, et autres
Publié: (2013)

Comparative analysis of glycemic control effectiveness and microvascular complications in patients with type 1 diabetes mellitus, treated with genetically engineered human insulin or human insulin analogues: A 10-year retrospective observational study
par: Marina V. Shestakova, et autres
Publié: (2016)

The value of patient-reported outcomes in patients with type 2 diabetes mellitus receiving insulin therapy: assessment of quality of life and hypoglycemia problems
par: Tat'yana Ivanovna Ionova, et autres
Publié: (2015)

The altered circadian pattern of basal insulin requirements – an early marker of autoimmune polyendocrine syndromes in type 1 diabetes mellitus
par: Pallayova Maria, et autres
Publié: (2020)

Síndrome de hipoglicemia autoinmune: Primeros casos en Chile
par: Lanas,Alejandra, et autres
Publié: (2015)

Insulin glargine 300 U/mL for basal insulin therapy in type 1 and type 2 diabetes mellitus
par: Lau IT, et autres
Publié: (2017)

Association Between Knowledge of Hypoglycemia and Likelihood of Experiencing Hypoglycemia Among Patients with Insulin-Treated Diabetes Mellitus
par: Almigbal TH
Publié: (2021)

Impaired hypoglycemia awareness in diabetes: epidemiology, mechanisms and therapeutic approaches
par: Vadim V. Klimontov
Publié: (2018)

Special aspects of concentrated insulins: basic characteristics and research findings
par: Tatiana Y. Demidova, et autres
Publié: (2019)

Age-adjustment of insulin pump settings in children and adolescents with type 1 diabetes mellitus
par: Dmitriy Nikitich Laptev, et autres
Publié: (2013)

Insulin pump therapy in children with diabetes mellitus: practice of Krasnoyarsk Krai
par: Tatiana Evgen'evna Taranushenko, et autres
Publié: (2012)

Two-way crossover comparison of insulin glargine and insulin detemir in basal-bolus therapy using continuous glucose monitoring
par: Abe S, et autres
Publié: (2011)

RELUCTANCE OF PATIENTS WITH DIABETES MELLITUS TO INSULIN THERAPY; PSYCHOLOGICAL INSULIN RESISTANCE
par: Umair Ali, et autres
Publié: (2021)

Hypoglycemia in type 2 diabetes patients treated with insulin: the advantages of continuous glucose monitoring
par: Vadim Valer'evich Klimontov, et autres
Publié: (2014)

Prospective study of efficacy and safety of insulin pump therapy in children and adolescents
par: Andrey Olegovich Emel'yanov, et autres
Publié: (2010)

91st Annual Conference on endocrine system diseases (ENDO, 2009), 10-13 June 2009, Washington
par: Natalya Nikitichna Volevodz
Publié: (2009)

Basal insulin therapy in patients with type 2 diabetes mellitus and poor control of glycemia by oral hypoglycemic agents: results of direct comparative study of insulin analogs Lantus and Levemir
par: Alsu Gafurovna Zalevskaya, et autres
Publié: (2010)

When basal insulin is not enough: successful strategies for insulin intensification in patients with type 2 diabetes mellitus
par: Elena V. Buryukova, et autres
Publié: (2017)

Immunogenicity and Efficacy of Insulin Glargine Biosimilar Ezelin versus Originator Insulin Glargine in Patients with Type 2 Diabetes
par: Tarigan TJE, et autres
Publié: (2021)

Dosing of U-100 insulin and associated outcomes among Medicare enrollees with type 1 or type 2 diabetes
par: Eby EL, et autres
Publié: (2015)

The results of open observational trial DIAMOND
par: Marina Vladimirovna Shestakova, et autres
Publié: (2011)

Early insulin therapy Coordination Council
par: Marina Vladimirovna Shestakova
Publié: (2012)